Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo

American Journal of Pathology

Volumn 160, Issue 4, 2002, Pages 1279-1292

  Ouafik, L'Houcine ^a   Sauze, Samantha ^a   Boudouresque, Françoise ^a   Chinot, Olivier ^a,b,c   Delfino, Christine ^a   Fina, Frédéric ^b   Vuaroqueaux, Vincent ^b   Dussert, Christophe ^a   Palmari, Jacqueline ^a   Dufour, Henri ^c   Grisoli, François ^c   Casellas, Pierre ^d   Brünner, Nils ^e   Martin, Pierre Marie ^a,b  

^a IFR Jean Roche   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c TIMONE HOSPITAL   (France)

^d SANOFI   (France)

^e FINSEN LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; ALPHA AMIDATING ENZYME; CALCITONIN RECEPTOR; GROWTH FACTOR; MESSENGER RNA; NEUTRALIZING ANTIBODY; PEPTIDE; POLYCLONAL ANTIBODY; REGULATOR PROTEIN;

AMIDATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER GRADING; CANCER INHIBITION; CONTROLLED STUDY; GLIOBLASTOMA; GLIOMA; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MITOGENESIS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OLIGODENDROGLIOMA; PARACRINE SIGNALING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CLASSIFICATION; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 0036117240     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62555-2     Document Type: Article

References (58)

1. Brain tumors
2. Microvessel density is a prognostic indicator for patients with astroglial brain tumors
3. Growth factors and cancer
4. Peptide amidation
5. The biosynthesis of neuropeptides: Peptide α-amidation
6. Comparison of peptidylglycine α-amidation activity in medullary thyroid carcinoma cells, pheochromocytomas, and serum
7. Characterization of an α-amidating activity in a human pancreatic tumour secreting vasoactive intestinal peptide (VIP)
8. Characterization of a peptide α-amidation activity in human plasma and tissues
9. Peptidylglycine α-amidating monooxygenase (PAM) immunoreactivity and messenger RNA in human pituitary and increased expression in pituitary tumours
10. Peptidylgtycine α-amidating mono-oxygenase (PAM) in Schwann cells and glia as well as neurons
11. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: A peptide superfamily
12. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma
13. Adrenomedullin, a multifunctional regulatory peptide
14. Adrenomedullin: Terra incognita
15. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells
16. PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a nonestrogenic mechanism in the human endometrium
17. Expression of adrenomedullin in normal human lung and in pulmonary tumors
18. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma
19. Production and secretion of adrenomedullin from glial cell tumors and its effects on cAMP production
20. Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor
21. Cloning and expression of cDNA encoding a rat adrenomedullin receptor
22. Identification of an orphan receptor gene as a type 1 calcitonin gene-related peptide receptor
23. A new calcitonin-receptor-like sequence in rat pulmonary blood vessels
24. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
25. The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor
26. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemo-sensitivity determined by a novel tetrazolium-based assay
27. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of radiosensitivity
28. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
29. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines
30. Human peptidylglycine α-amidating monooxygenase: cDNA, cloning, and functional expression of a truncated form in COS cells
31. Cloning and characterization of cDNA encoding a precursor for adrenomedullin
32. Developmental regulation of peptidylglycine α-amidating monooxygenase (PAM) in rat heart atrium and ventricule: Tissue-specific changes in distribution of PAM activity, mRNA levels, and protein forms
33. 4
34. A novel method for real-time quantitative RT-PCR
35. Real-time quantitative PCR
36. Coexpression of receptors for adrenomedullin, calcitonin gene-related peptide and amylin in pancreatic β-cells
37. Adrenomedullin binds with high affinity, elevates cyclic AMP, and stimulates c-fos mRNA in C6 glioma cells
38. 131l-labelled human growth hormone of high specific radioactivity
39. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
40. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide
41. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells
42. Glioblas toma
43. Thyroid hormone regulation of peptidylglycine α-amidating monooxygenase expression in anterior pituitary gland
44. Autocrine growth loops dependent on peptidyl α-amidating enzyme as targets for novel tumor cell growth inhibitors
45. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer
46. A public database for gene expression in human cancer
47. The World Health Organization classification of nervous system tumors in experimental neuro-oncology
48. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: A possible promotion mechanism of carcinogenesis
49. Induction of adrenomedullin during hypoxia in cultured human glioblastoma cells
50. Hypoxia induces adrenomedullin gene expression and secretion in cultured human umbilical vein endothelial cells
51. Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage
52. Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders
53. Specific adrenomedullin binding sites in the human brain
54. Insulin-like growth factor expression in human cancer cell lines
55. An angiogenic growth factor is expressed in human glioma cells
56. Growth factor-mediated angiogenesis in the malignant progression of glial tumors